Diagnostic pathways and clinical significance of desquamative gingivitis

Journal of Periodontology

Volumn 79, Issue 1, 2008, Pages 4-24

  Russo, Lucio Lo ^a,d   Fedele, Stefano ^b   Guiglia, Rosario ^a   Ciavarella, Domenico ^c   Muzio, Lorenzo Lo ^c   Gallo, Pio ^a   Liberto, Chiara Di ^a   Campisi, Giuseppina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF FOGGIA   (Italy)

^d NONE   (Italy)

Author keywords

Desquamative gingivitis; Diagnosis; Erythema multiforme; Lichen planus; Pemphigoid; Pemphigus

Indexed keywords

BLISTER; DIFFERENTIAL DIAGNOSIS; ERYTHEMA; ERYTHEMA MULTIFORME; GINGIVITIS; HUMAN; IMMUNOLOGY; LICHEN PLANUS; MUCOUS MEMBRANE PEMPHIGOID; PATHOLOGY; PEMPHIGUS; PROGNOSIS; REVIEW;

BLISTER; DIAGNOSIS, DIFFERENTIAL; ERYTHEMA; ERYTHEMA MULTIFORME; GINGIVITIS; HUMANS; LICHEN PLANUS, ORAL; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGUS; PROGNOSIS;

EID: 38549092725     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070231     Document Type: Review

References (148)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Tricamo MB, Rees TD, Hallmon WW, Wright JM, Cueva MA, Plemons JM. Periodontal status in patients with gingival mucous membrane pemphigoid. J Periodontol 2006;77:398-405.
3. Ramon-Fluixa C, Bagan-Sebastian J, Milian-Masanet M, Scully C. Periodontal status in patients with oral lichen planus: A study of 90 cases. Oral Dis 1999;5: 303-306.
4. American Academy of Periodontology. Oral features of mucocutaneous disorders (position paper). J Periodontol 2003;74:1545-1556.
5. Prinz H. Chronic diffuse desquamative gingivitis. Dental Cosmos 1932;74:332-333.
6. Robinson NA, Wray D. Desquamative gingivitis: A sign of mucocutaneous disorders - A review. Aust Dent J 2003;48:206-211.
7. Mignogna MD, Lo Russo L, Fedele S. Gingival involvement of oral lichen planus in a series of 700 patients. J Clin Periodontol 2005;32:1029-1033.
8. Glickman I, Smulow J. Chronic desquamative gingivitis: Its nature and treatment. J Periodontol 1964;35: 397-405.
9. Mignogna MD, Lo Muzio L, Bucci E. Clinical features of gingival pemphigus vulgaris. J Clin Periodontol 2001;28:489-493.
10. Bagan J, Lo Muzio L, Scully C. Mucosal disease series. Number III. Mucous membrane pemphigoid. Oral Dis 2005;11:197-218.
11. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. update on mucous membrane pemphigoid: A heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:56-68.
12. Kurihara M, Nishimura F, Hashimoto T, et al. Immunopathological diagnosis of cicatricial pemphigoid with desquamative gingivitis. A case report. J Periodontol 2001;72:243-249.
13. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K. Number V oral liehen planus: Clinical features and management. Oral Dis 2005;11:338-349.
14. Mollaoglu N. Oral lichen planus: A review. Br J Oral Maxillofac Surg 2000;38:370-377.
15. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005;366: 61-73.
16. Black M, Mignogna MD, Scully C. Number II. Pemphigus vulgaris. Oral Dis 2005;11:119-130.
17. Korman N. Pemphigus. J Am Acad Dermatol 1988; 18:1219-1238.
18. Nisengard RJ, Rogers RS 3rd. The treatment of desquamative gingival lesions. J Periodontol 1987; 58:167-172.
19. Nisengard RJ, Neiders M. Desquamative lesions of the gingiva. J Periodontol 1981;52:500-510.
20. Markopoulos AK, Antoniades D, Papanayotou P, Trigonidis G. Desquamative gingivitis: A clinical, histopathologic, and immunologic study. Quintessence Int 1996;27:763-767.
21. Rogers RS 3rd, Sheridan PJ, Nightingale SH. Desquamative gingivitis: Clinical, histopathologic, immunopathologic, and therapeutic observations. J Am Acad Dermatol 1982;7:729-735.
22. Yih WY, Maier T, Kratochvil FJ, Zieper MB. Analysis of desquamative gingivitis using direct immunofluorescence in conjunction with histology. J Periodontol 1998;69:678-685.
23. Vaillant L, Chauchaix-Barthes S, Huttenberger B, et al. Chronic desquamative gingivitis syndrome: Retrospective analysis of 33 cases (in French). Ann Dermatol Venereol 2000; 127:381-387.
24. Yih WY, Richardson L, Kratochvil FJ, Avera SP, Zieper MB. Expression of estrogen receptors in desquamative gingivitis. J Periodontol 2000;71:482-487.
25. Scully C, Porter SR. The clinical spectrum of desquamative gingivitis. Semin Cutan Med Surg 1997;16:308-313.
26. Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 2005;11: 261-267.
27. Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin 2003;21:195-205.
28. Jorizzo JL, Salisbury PL, Rogers RS 3rd, et al. Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis? J Am Acad Dermatol 1992;27:389-394.
29. Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A. Environment and systemic lupus erythematosus: An overview. Autoimmunity 2005;38:465-472.
30. Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC. Chronic graft versus host disease of oral mucosa: Review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101: 175-183.
31. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Rev 2006;20:15-27.
32. Sato M, Tokuda N, Fukumoto T, Mano T, Sato T, Cleyama Y. Immunohistopathological study of the oral lichenoid lesions of chronic GVHD. J Oral Pathol Med 2006;35:33-36.
33. Lorenzana ER, Rees TD, Glass M, Detweiler JG. Chronic ulcerative stomatitis: A case report. J Periodontol 2000;71:104-111.
34. Lewis JE, Beutner EH, Rostami R, Chorzelski TP. Chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibodies. Int J Dermatol 1996;35:272-275.
35. Roman CC, Yuste CM, Gonzalez MA, Gonzalez AP, Lopez G. Plasma cell gingivitis. Cutis 2002;69:41-45.
36. Porter SR, Scully C, Midda M, Eveson JW. Adult linear immunoglobulin A disease manifesting as desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1990;70:450-453.
37. O'Regan E, Bane A, Flint S, Timon C, Toner M. Linear IgA disease presenting as desquamative gingivitis: A pattern poorly recognized in medicine. Arch Otolaryngol Head Neck Surg 2004;130:469-472.
38. Porter SR, Bain SE, Scully CM. Linear IgA disease manifesting as recalcitrant desquamative gingivitis. Oral Surg Oral Med Oral Pathol 1992;74:179-182.
39. Economopoulou P, Laskaris G. Dermatitis herpetiformis: Oral lesions as an early manifestation. Oral Surg Oral Med Oral Pathol 1986;62:77-80.
40. Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: A guide for dermatologists. Am J Clin Dermatol 2003;4:13-20.
41. Campos M, Silvente C, Lecona M, Suarez R, Lazaro P. Epidermolysis bullosa acquisita: Diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol 2006;31:71-73.
42. Tilakaratne W, Dissanayake M. Paraneoplastic pemphigus: A case report and review of literature. Oral Dis 2005;11:326-329.
43. Wade MS, Black MM. Paraneoplastic pemphigus: A brief update. Australas J Dermatol 2005;46:1-8; quiz 9-10.
44. Setterfield J, Shirlaw PJ, Lazarova Z, et al. Paraneoplastic cicatricial pemphigoid. Br J Dermatol 1999;141:127-131.
45. Coelho S, Reis JP, Tellechea O, Figueiredo A, Black M. Paraneoplastic pemphigus with clinical features of lichen planus associated with low-grade B cell lymphoma. Int J Dermatol 2005;44:366-371.
46. Gravitis K, Daley TD, Lochhead MA. Management of patients with foreign body gingivitis: Report of 2 cases with histologie findings. J Can Dent Assoc 2005;71:105-109.
47. Brice DM, Danesh-Meyer MJ. Oral lesions in patients with psoriasis: Clinical presentation and management. J Periodontol 2000;71:1896-1903.
48. Younai FS, Phelan JA. Oral mucositis with features of psoriasis: Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:61-67.
49. Zhu JF, Kaminski MJ, Pulitzer DR, Hu J, Thomas HF. Psoriasis: Pathophysiology and oral manifestations. Oral Dis 1996;2:135-144.
50. Mariotti A. Desquamative gingivitis: Revisited. Todays FDA 1991;3:1C-2C.
51. Ariyawardana A, Tilakaratne WM, Dissanayake M, et al. Oral pemphigus vulgaris in children and adolescents: A review of the literature and a case report. Int J Paediatr Dent 2005;15:287-293.
52. Sklavounou A, Laskaris G. Childhood cicatricial pemphigoid with exclusive gingival involvement. Int J Oral Maxillofac Surg 1990;19:197-199.
53. Laeijendecker R, Van Joost T, Tank B, Oranje AP, Neumann H. Oral lichen planus in childhood. Pediatr Dermatol 2005;22:299-304.
54. Roche C, Field EA. Benign mucous membrane pemphigoid presenting as desquamative gingivitis in a 14-year-old child. Int J Paediatr Dent 1997;7:31-34.
55. Scully C, Laskaris G. Mucocutaneous disorders. Periodontol 2000 1998;18:81-94.
56. Barnett ML. Pemphigus vulgaris presenting as a gingival lesion. A case report. J Periodontol 1988;59:611-614.
57. Stoopler ET, Sollecito TP, DeRossi SS. Desquamative gingivitis: Early presenting symptom of mucocutaneous disease. Quintessence Int 2003;34:582-586.
58. Vaillant L, Arbeille B, Goga D, de Muret A, Prime A, Lorette G. Cicatricial pemphigoid disclosed by superficial desquamative gingivitis. Clinical and immunoelectron microscopic study of a case (in French). Ann Dermatol Venereol 1990;117:613-620.
59. Laforest C, Huilgol SC, Casson R, Selva D, Leibovitch I. Autoimmune bullous diseases: Ocular manifestations and management. Drugs 2005;65:1767-1779.
60. Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol 1968;25:31-42.
61. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988;17:213-218.
62. Brennan MT, Valerin MA, Napenas JJ, Lockhart PB. Oral manifestations of patients with lupus erythematosus. Dent Clin North Am 2005;49:127-141.
63. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13:350-365.
64. Sirois D, Leigh JE, Sollecito TP. Oral pemphigus vulgaris preceding cutaneous lesions: Recognition and diagnosis. J Am Dent Assoc 2000;131:1156-1160.
65. Solomon LW, Aguirre A, Neiders M, et al. Chronic ulcerative stomatitis: Clinical, histopathologic, and immunopathologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:718-726.
66. Eisen D. The clinical manifestations and treatment of oral lichen planus. Dermatol Clin 2003;21:79-89.
67. Fleming TE, Korman NJ. Cicatricial pemphigoid. J Am Acad Dermatol 2000;43:571-591; quiz 591-574.
68. Scully C, Paes De Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: The manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 1999;140:84-89.
69. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: Is there any evidence? Oral Oncol 2004;40:120-130.
70. Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006;116:1159-1166.
71. Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol 2005;14:861-875.
72. Scully C, Bagan JV, Black M, et al. Epithelial biology. Oral Dis 2005;11:58-71.
73. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature. Oral Surg Oral Med Oral Pathol 1994;77:555-571.
74. Borrego L, Maynard B, Peterson EA, et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 1996;148:897-909.
75. Liu Z, Zhou X, Shapiro SD, et al. The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 2000;102:647-655.
76. Liu Z, Shapiro SD, Zhou X, et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 2000;105:113-123.
77. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: Report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:40-51.
78. Regezi JA, Dekker NP, MacPhail LA, Lozada-Nur F, McCalmont TH. Vascular adhesion molecules in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:682-690.
79. Sugermann PB, Savage NW, Seymour GJ, Walsh LJ. Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus? J Oral Pathol Med 1996;25:219-224.
80. Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T. Late development of antides-moglein 1 antibodies in pemphigus vulgaris: Correlation with disease progression. Br J Dermatol 1999;141:1084-1087.
81. Kowalewski C, Mackiewicz W, Schmitt D, Jablonska S, Haftek M. Cell-cell junctions in acantholytic diseases. Junction proteins in nonimmune and autoimmune acantholysis. Arch Dermatol Res 2001;293:1-11.
82. Kitajima Y, Aoyama Y, Seishima M. Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell detachment induced by pemphigus IgG in cultured keratinocytes: Involvement of protein kinase C. J Investig Dermatol Symp Proc 1999;4:137-144.
83. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosls 2004;9:131-143.
84. Mignogna MD, Lo Muzio L, Zeppa P, Ruocco V, Bucci E. Immunocytochemical detection of auto-antibody deposits in Tzanck smears from patients with oral pemphigus. J Oral Pathol Med 1997;26:254-257.
85. Neville BW, Damm DD, Allen CM, Bouquot JE. Pemphigus. In: Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 2002:664-667.
86. Kokuba H, Aurelian L, Burnett J. Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: Interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatol 1999;113:808-815.
87. Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): A viral disease with an autoimmune component. Dermatol Online J 2003;9:1.
88. Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-714.
89. Iwai K, Miyawaki T, Takizawa T, et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994;84:1201-1208.
90. Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006;92:1-69.
91. Neville BW, Damm DD, Allen CM, Bouquot JE. Liehen planus. In: Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 2002:680-685.
92. Neville BW, Damm DD, Allen CM, Bouquot JE. Lupus erythematosus. In: Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 2002:689-692.
93. Neville BW, Damm DD, Allen CM, Bouquot JE. Erythema multiforme. In: Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 2002:674-677.
94. Lombardi T, Kuffer R, Dubrez B. Polishing-paste-induced silica granuloma of the gingiva. Dermatology 2001;203:177-179.
95. Neville BW, Damm DD, Allen CM, Bouquot JE. Psoriasis. In: Oral and Maxillofacial Pathology. Philadelphia: W.B. Saunders; 2002:687-688.
96. Vincent SD, Fotos PQ, Baker KA, Williams TP. Oral lichen planus: The clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990;70:165-171.
97. Helander SD, Rogers RS 3rd. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 1994;30:65-75.
98. Hall RP, Lawley TJ. Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis. J Immunol 1985;135: 1760-1765.
99. Fry L. Dermatitis herpetiformis: Problems, progress and prospects. Eur J Dermatol 2002;12:523-531.
100. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370-379.
101. Cheng SW, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M, Nishikawa T. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002;147:261-265.
102. Mutasim DF, Adams BB. Cicatricial pemphigoid diagnosed by the use of indirect immunofluorescence. J Cutan Med Surg 2000;4:205-207.
103. Mutasim DF. The accuracy of indirect immunofluorescence on sodium chloride-split skin in differentiating subepidermal bullous diseases. Arch Dermatol 1997;133:1158-1160.
104. Parisi E, Raghavendra S, Werth VP, Sollecito TP. Modification to the approach of the diagnosis of mucous membrane pemphigoid: A case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:182-186.
105. Lazarova Z, Yancey KB. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations. J Am Acad Dermatol 1996;35:398-403.
106. Barnadas MA, Gelpi C, Curell R, de Moragas JM, Alomar A. Repeat direct immunofluorescence (DIF) test, using 1 M NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction. J Cutan Pathol 1999;26:37-41.
107. Mimouni D, Anhalt GJ, Lazarova Z, et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002;147:725-732.
108. Liu AY, Valenzuela R, Helm TN, Camisa C, Melton AL, Bergfeld WF. Indirect immunofluorescence on rat bladder transitional epithelium: A test with high specificity for paraneoplastic pemphigus. J Am Acad Dermatol 1993;28:696-699.
109. Helou J, Allbritton J, Anhalt GJ. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995;32:441-447.
110. Jaremko WM, Beutner EH, Kumar V, et al. Chronic ulcerative stomatitis associated with a specific immunologie marker. J Am Acad Dermatol 1990;22:215-220.
111. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: Results of an international prospective study. Arch Dermatol 2002;138:1019-1024.
112. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity 2005;38:507-518.
113. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004;15:221-239.
114. Gupta A, Bansal D, Dass R, Das A. Transfusion associated graft versus host disease. Indian Pediatr 2004;41:1260-1264.
115. Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Neoplasms associated with paraneoplastic pemphigus: A review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004;40:553-562.
116. Cozzani E, Cacciapuoti M, Parodi A, Rebora A. Pemphigus following tetanus and diphtheria vaccination. Br J Dermatol 2002;147:188-189.
117. Mignogna MD, Lo Muzio L, Ruocco E. Pemphigus induction by influenza vaccination. Int J Dermatol 2000-39:800.
118. Yiannias JA, el-Azhary RA, Hand JH, Pakzad SY, Rogers RS 3rd. Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol 2000;42:177-182.
119. Helm TN, Camisa C, Valenzuela R, Alien CM. Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia. Oral Surg Oral Med Oral Pathol 1993;75:209-213.
120. Wray D. Pyostomatitis vegetans. Br Dent J 1984;157:316-318.
121. Setterfield J, Shirlaw PJ, Bhogal BS, Tilling K, Challacombe SJ, Black MM. Cicatricial pemphigoid: Serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 1999;140:645-650.
122. Holmstrup P, Schiotz AW, Westergaard J. Effect of dental plaque control on gingival lichen planus. Oral Surg Oral Med Oral Pathol 1990;69:585-590.
123. Whiteside OJ, Martinez Devesa P, Ali I, Capper JW. Mucous membrane pemphigoid: Nasal and laryngeal manifestations. J Laryngol Otol 2003;117:885-888.
124. Tokano Y, Morimoto S, Amano H, et al. The relationship between initial clinical manifestation and long-term prognosis of patients with systemic lupus erythematosus. Mod Rheumatol 2005;15:275-282.
125. Williams TR, Haider-Shah H. Diffuse esophageal stricture secondary to esophageal lichen planus. Abdom Imaging 2005;30:355-357.
126. Goldstein AT, Anhalt GJ, Klingman D, Burrows LJ. Mucous membrane pemphigoid of the vulva. Obstet Gynecol 2005;105:1188-1190.
127. Setterfield JF, Neill S, Shirlaw PJ, et al. The vulvo-vaginal gingival syndrome: A severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006;55:98-113.
128. Rodstrom PO, Jontell M, Mattsson U, Holmberg E. Cancer and oral lichen planus in a Swedish population. Oral Oncol 2004;40:131-138.
129. Epstein JB, Wan LS, Gorsky M, Zhang L. Oral lichen planus: Progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:32-37.
130. Mignogna MD, Lo Russo L, Fedele S, Ruoppo E, Califano L, Lo Muzio L. Clinical behaviour of malignant transforming oral lichen planus. Eur J Surg Oncol 2002;28:838-843.
131. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: A 5-year experience. Oral Oncol 2001;37:262-267.
132. Mignogna MD, Fedele S, Lo Russo L. Dysplasia/neoplasia surveillance in oral lichen planus patients: A description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 2006;42:819-824.
133. Yeh SW, Ahmed B, Sami N, Razzaque Ahmed A. Blistering disorders: Diagnosis and treatment. Dermatol Ther 2003;16:214-223.
134. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994;77:598-604.
135. Gonzalez-Moles MA, Ruiz-Avila I, Rodriguez-Archilla A, et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:688-692.
136. Gonzalez-Moles MA, Morales P, Rodriguez-Archilla A, Isabel IR, Gonzalez-Moles S. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:264-270.
137. Carrozzo M, Carbone M, Broccoletti R, Garzino-Demo P, Gandolfo S. Therapeutic management of mucous membrane pemphigoid. Report of 11 cases (in Italian). Minerva Stomatol 1997;46:553-559.
138. Suresh L, Martinez Calixto LE, Radfar L. Successful treatment of mucous membrane pemphigoid with tacrolimus. Spec Care Dentist 2006;26:66-70.
139. Huilgol SC, Black MM. Management of the immunobullous disorders. I. Pemphigoid. Clin Exp Dermatol 1995;20:189-201.
140. Sacher C, Hunzelmann N. Cicatricial pemphigoid (mucous membrane pemphigoid): Current and emerging therapeutic approaches. Am J Clin Dermatol 2005;6:93-103.
141. Carrozzo M, Gandolfo S. The management of oral lichen planus. Oral Dis 1999;5:196-205.
142. Shichinohe R, Shibaki A, Nishie W, Tateishi Y, Shimizu H. Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus. J Eur Acad Dermatol Venereol 2006;20:66-68.
143. Becker JC, Houben R, Vetter CS, Brocker EB. The carcinogenic potential of tacrolimus ointment beyond immune suppression: A hypothesis creating case report. BMC Cancer 2006;6:7.
144. Yeh SW, Sami N, Ahmed RA. Treatment of pemphigus vulgaris: Current and emerging options. Am J Clin Dermatol 2005;6:327-342.
145. Katz J, Livneh A, Shemer J, Danon YL, Peretz B. Herpes simplex-associated erythema multiforme (HAEM): A clinical therapeutic dilemma. Pediatr Dent 1999;21:359-362.
146. Stewart MG, Duncan NO 3rd, Franklin DJ, Friedman EM, Sulek M. Head and neck manifestations of erythema multiforme in children. Otolaryngol Head Neck Surg 1994;111:236-242.
147. Vodegel RM, de Jong MC, Pas HH, Jonkman MF. IgA-mediated epidermolysis bullosa acquisita: Two cases and review of the literature. J Am Acad Dermatol 2002;47:919-925.
148. Staines KS, Felix DH, Forsyth A. Desquamative gingivitis, sole manifestation of tosylamide/formaldehyde resin allergy. Contact Dermatitis 1998;39:90.